Education and treatment adherence during the COVID-19 pandemic. Response to: 'Adherence to medication in patients with rheumatic diseases during COVID-19 pandemic' by Khabbazi
et al
Ann Rheum Dis
.
2022 Oct;81(10):e201.
doi: 10.1136/annrheumdis-2020-218791.
Epub 2020 Sep 7.
Authors
Rita Angélica Pineda-Sic
1
,
Griselda Serna-Peña
1
,
Jesus Alberto Cardenas-de la Garza
1
,
Sergio A Torres-Castillo
2
,
Dionicio Angel Galarza-Delgado
3
,
Diana Elsa Flores-Alvarado
1
Affiliations
1
Rheumatology, Universidad Autonoma de Nuevo Leon, Monterrey, Nuevo Leon, Mexico.
2
Servicio de Neurología, Universidad Autonoma de Nuevo Leon, Monterrey, Nuevo Leon, Mexico.
3
Rheumatology, Universidad Autonoma de Nuevo Leon, Monterrey, Nuevo Leon, Mexico dgalarza@medicinauanl.mx.
PMID:
32895238
DOI:
10.1136/annrheumdis-2020-218791
No abstract available
Keywords:
antirheumatic agents; autoimmune diseases; therapeutics.
Publication types
Letter
Comment
MeSH terms
COVID-19*
Humans
Medication Adherence
Pandemics
Rheumatic Diseases* / drug therapy
Treatment Adherence and Compliance